A longitudinal quantitative study documenting homoeopathic treatment outcomes in chronic dermatological conditions in adults using the Patient Response Assessment Tool after Homoeopathic Treatment version 2.0 (PRATHoT v.2.0)

The term "chronic dermatological condition" is an umbrella term used to describe skin disorders characterized by repeated episodes and prolonged duration. The American Academy of Dermatology (AAD) generally defines chronic dermatological conditions as those that are long-lasting or persistent, often with periods of flare-ups and remission. These conditions can significantly impact a person’s quality of life due to their long duration and potential for symptom recurrence.  Conditions such as acne, eczema, psoriasis, and rosacea not only affect the skin but also have significant psychological and social impacts. Their visible nature often leads to emotional distress, reduced self-esteem, and, in some cases, social withdrawal or clinical depression. These effects are experienced universally, across all cultures, age groups, and socioeconomic backgrounds, making skin disorders among the most common medical complaints worldwide. Effective treatment of these conditions can improve both physical appearance and mental well-being, highlighting the importance of addressing the broader impacts of dermatological conditions beyond just the surface symptoms. The Global Burden of Disease project 2017 has shown that dermatological conditions continue to be the 4th leading cause of nonfatal disease burden world-wide. Under such circumstances, we intend to undertake this research project ‘A longitudinal quantitative study documenting homoeopathic treatment outcomes in chronic dermatological conditions in adults using the Patient Response Assessment Tool after Homoeopathic Treatment version 2.0 (PRATHoT v.2.0) on 300 patients suffering from chronic dermatological conditions at the outpatient’s department of D. N. De Homoeopathic Medical College and Hospital. Assessment will be done by PRATHoT [Primary outcome measure], ORIDL [Secondary outcome measure], DLQI[Secondary outcome measure] every month up to 3 months.